365NEWSX
365NEWSX
Subscribe

Welcome

I'm 52 and have had one AstraZeneca jab - should I be worried about my second? - Telegraph.co.uk

I'm 52 and have had one AstraZeneca jab - should I be worried about my second? - Telegraph.co.uk

I'm 52 and have had one AstraZeneca jab - should I be worried about my second? - Telegraph.co.uk
Apr 11, 2021 1 min, 51 secs

The text from the NHS to inform me it’s time for my second Covid jab.

Now, though, after the events of last week, and with my second dose due in the next few weeks, even ardent pro-vaxxers like me are starting to ask a few questions.

Research is continuing into the possibility of a – vanishingly small – risk of blood clots after the AstraZeneca jab.

Up to March 21, the Medicines and Healthcare products Regulatory Agency (MHRA) received 79 complaints of blood clots accompanied by low platelet count, in all people who had received their first dose of the vaccine, out of 20 million doses given.

Last Wednesday, the Joint Committee on Vaccination and Immunisation (JCVI) announced that people under 30 will now be offered different vaccines.

After all, the German regulators have advised that under-60s who have received their first dose of the AstraZeneca vaccine should be given a second dose of the rival Pfizer or Moderna, and France has now followed suit, advising under-55s to do the same.

Britain’s regulator said last week that the benefits of the jab still far outweigh the risks for the majority of people, and anyone who has had a first AstraZeneca jab should continue with it for their second.

“The chances of dying from a blood clot caused by a vaccine are similar to the chances of being struck by lightning,” says Tim Spector, professor of genetic epidemiology at King’s College, London and leader of the ZOE Covid symptom app, which logs the experience of more than four million contributors globally.

The risk of vaccine blood clots is extremely rare.

We have data on 600,000 AstraZeneca loggers, and we haven’t yet seen a severe clotting case.” Indeed, the chance of getting a blood clot is about one in 250,000 and the risk of dying after a vaccine in all ages is less than one in a million, based on UK data analysed by regulators.

“Long Covid is more prevalent in old people, younger women, and those with a higher BMI.

Experts stress that it’s vital to return for your second vaccine dose.

“Those who have received their first AstraZeneca should continue to be offered the second dose of AstraZeneca according to the schedule.”?

Summarized by 365NEWSX ROBOTS

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED